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      BSTRACT
A general overview of tricuspid valve dysplasia in dogs is presented in this review. This con-
genital disease has been described in numerous large dog breeds but especially the Labrador 
retriever is predisposed. The condition is relatively uncommon, with a prevalence of approxi-
mately seven percent of all congenital heart diseases in dogs. The asymptomatic phase may last 
for several years and depends on the severity of the valve malformation. In the clinical phase, 
exercise intolerance, fatigue, anorexia, cardiac cachexia, dyspnea and signs of right-sided conges-
tive heart failure can be present. Echocardiography including Doppler imaging is warranted to 
confirm the diagnosis. Curative treatment involves surgical valve replacement but is technically 
challenging and still in its experimental phase in dogs. As such, treatment in dogs involves the 
administration of supportive medication once the dogs develop symptoms of congestive heart 
failure and consists of diuretics, ace-inhibitors and positive inotropic drugs.
SAMENVATTING
In dit artikel wordt een gedetailleerd overzicht gegeven van de verschillende aspecten van tricus-
pidalisklepdysplasie bij honden. Deze aangeboren aandoening werd beschreven bij diverse grote hon-
denrassen maar voornamelijk de labrador-retriever is gepredisponeerd. Tricuspidalisklepdysplasie is 
relatief zeldzaam met een prevalentie van ongeveer zeven procent van alle congenitale hartafwijkingen 
bij de hond. De asymptomatische fase kan meerdere jaren duren en hangt voornamelijk af van de ernst 
van de afwijking. Tijdens de klinische fase kunnen inspanningsintolerantie, vermoeidheid, anorexie, 
cardiale cachexie, dyspneu en tekenen van rechterharthalen aanwezig zijn. Echocardiografie inclu- 
sief een doppleronderzoek is noodzakelijk om de diagnose te bevestigen. Een definitieve behandeling 
bestaat uit het chirurgisch vervangen van de klep maar dit is technisch moeilijk en bevindt zich bij hon-
den nog in de experimentele fase. Een ondersteunende therapie wordt ingesteld zodra de hond symp-
tomen van congestief hartfalen ontwikkelt en bestaat uit het toedienen van diuretica, ace-inhibitoren 
en positief-inotrope farmaca.
A
INTRODUCTION
Tricuspid valve dysplasia (TVD) is a congenital 
heart malformation that usually manifests itself as 
tricuspid valve insufficiency and more rarely as tri-
cuspid stenosis (Kittleson, 1998; Barre et al., 2012; 
Beijerink et al., 2017). When the tricuspid valve leaf-
lets are displaced more apically in the right ventricle 
(sometimes called “atrialization of the ventricle”), the 
disease is called Ebstein’s anomaly. In humans, both 
TVD and Ebstein’s anomaly are uncommon diseases 
that show poor prognosis with high mortality rates in 
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utero and shortly after birth, because severe abnormal 
morphology of the valve results in early death (Barre 
et al., 2012). In less severe cases, the disease corre-
sponds with an average mortality risk of only 1 to 1.4 
percent per year during infancy and adulthood (Mal-
vindi and Viola, 2015). In dogs, the initial prevalence 
of TVD in utero is unknown. In juvenile and adult 
dogs, the prognosis is similar to humans and depends 
primarily on the severity of the malformation. Dogs 
with small insufficiencies usually have a normal life 
span (Beijerink et al., 2017). In human medicine, cu-
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rative treatment entails artificial valve repair or re-
placement, while in dogs, only medicinal therapy is 
currently used as surgical repair is still experimental 
(Arai et al., 2011; Bristow et al., 2017).
Embryology, anatomy and physiology of atrioven-
tricular valves
In mammals, atrioventricular valve formation oc-
curs in the late phase of the first trimester of gestation. 
The leaflets of the tricuspid and mitral valve originate 
from the atrioventricular cushions and a diverticula-
tion of the ventricular wall (McGeady et al., 2006). 
The valve tissue receives myocardial signals leading 
to mesenchymal cell death, transformation of endo-
cardial cells and ultimately, to formation of the valve 
leaflets. Because the valves partially derive from mes-
enchymal tissue that was originally attached to the 
myocardium, the valves remain anchored by muscu-
lar structures to the ventricular walls. These structures 
are gradually replaced by dense connective tissue, 
the chordae tendineae, which ultimately connect the 
valvular leaflets to the papillary muscles (Kittleson 
and Kienle, 1998; Fox et al., 1999; Andelfinger et al., 
2003; McGeady et al., 2006). 
In humans, the tricuspid valve (TV) is composed 
of three leaflets while in dogs, it has been reported 
that the TV may consist of two to five leaflets (Alves 
et al., 2008). The majority of dogs have a TV that is 
composed of three or four leaflets. In valves contain-
ing two or three leaflets, the septal leaflet is larger 
than the mural (parietal) leaflet and, if present, angu-
lar leaflet. The septal leaflet is semicircular in shape 
and located superior to the interventricular septum. 
The mural leaflet is more flexible. It starts at the tri-
cuspid annulus and extends slightly more towards the 
right ventricular apex than the septal leaflet. Conse-
quently, the mural leaflet is more essential than the 
septal leaflet for an effective closure of the valve dur-
ing systole (Kittleson and Kienle, 1998; Sisson et al., 
1999; Chetboul et al., 2004). In dogs with valves that 
are composed of four leaflets, the fourth leaflet is lo-
cated between the septal and the mural leaflet and is 
called the septoventral leaflet. Exceptionally, a fifth 
leaflet may be present between the septal and angu-
lar leaflet. In these cases, the septal and mural leaflets 
are less prominent (Alves et al., 2008). The leaflets 
are anchored by the chordae tendineae to the papillary 
muscles and papillae. These three structures prevent 
the leaflets to collapse into the atrium during systole 
(Kittleson and Kienle, 1998). 
During early diastole, ventricular pressures fall 
rapidly and when the ventricular diastolic pressures 
become equal to the atrial pressures, the atrioventricu-
lar valves open passively, resulting in a rapid blood 
flow from the atria into the ventricles. At the end of 
the diastole, the velocity of the blood flow across the 
valves slows down as the ventricular filling peaks. At 
this point, the atrioventricular valves partially close. 
During atrial systole, the valves reopen and provide 
the final ventricular filling. The atrioventricular valves 
close when the ventricular pressure exceeds atrial 
pressure, resulting in the initiation of the ventricular 
systole. (Kittleson and Kienle, 1998; Ware, 2013). 
Pathophysiology of tricuspid valve dysplasia
Tricuspid valve dysplasia represents an abnormal 
structure or position of the valve leaflets, the chordae 
tendineae and/or the papillary muscles and includes 
elongation, shortening, fusion, and/or thickening of 
the chordae tendineae, direct insertion of the TV onto 
the papillary muscles and atrophy, hypertrophy, fu-
sion and/or malpositioning of the papillary muscles 
(Sisson et al., 1999; Tran-Cong et al., 2004; Boon, 
2011; Beijerink et al., 2017).
In human medicine, a grading system based on 
the type of malformation has been described for TVD 
(Formigari et al., 1993). These grades negatively 
correlate with the developmental differentiation of 
the valve during embryogenesis. Grade I represents 
myxoid changes of the leaflets and chordae tendin-
eae; grade II represents thickened and often retracted 
leaflets, and grade III represents extreme dysplasia of 
the leaflets (Formigari et al., 1993). More recently, a 
novel grading system that could guide surgical man-
agement, has been published (Gupta et al., 2011).
The most common manifestation of TVD in hu-
mans and dogs is valve insufficiency. The increased 
systolic inflow creates right atrial volume overload 
resulting in an atrial dilation and ventricular accom-
modation (Ware, 2013; Beijerink et al., 2017). The in-
creased right ventricular end diastolic volume causes 
eccentric hypertrophy of the right ventricle and allows 
the right ventricle to eject a larger volume to compen-
sate for the decreased stroke volume caused by the 
regurgitation over the TV. In this stage, the heart can 
still compensate the TVD (Sisson et al., 1999). 
When the disease progresses, the right heart size 
keeps on increasing and, as such, the TV annulus wid-
ens as well (Kittleson, 1998). It has been proven in 
other animal species that reactivation of the embryonic 
pathways for leaflet growth may result in the adaptation 
of the leaflets, but, obviously, this increase in size does 
not compensate adequately to prevent further worsen-
ing of the regurgitation (Chan et al., 2017). This vicious 
circle ultimately results in a massive regurgitation with 
loss of compensatory mechanisms, an increased right 
atrial pressure and right-sided congestive heart failure, 
in combination with systemic congestion and a de-
creased forward flow into the pulmonary vasculature. 
The left heart becomes underloaded and in the end, a 
decrease in systemic blood flow occurs. In rare cases, 
atrial fibrillation and supraventricular tachycardia have 
been described in dogs with severe TVD (Kittleson 
and Kienle, 1998; Sisson et al., 1999; Tilly and Smith, 
2011; Ware, 2013; Beijerink et al., 2017). 
Tricuspid stenosis is another potential manifesta-
tion of TVD. Congenital stenosis has been less fre-
quently described in dogs than valve insufficiency, 
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but both abnormalities may also be present concomi-
tantly in the same valve (Sisson et al., 1999). In hu-
mans, true congenital tricuspid stenosis appears to be 
rare; yet acquired tricuspid stenosis is relatively com-
mon in patients with rheumatic heart disease (Brown 
and Thomas, 1995). The stenotic component may 
cause a ventricular inflow obstruction with an ele- 
vated atrial pressure and an increased peak velocity of 
the blood flow from the atrium in the ventricle at the 
level of the TV during diastole. In severe cases of TV 
stenosis, a limited cardiac output results in a hypo- 
plastic right ventricle with secondary hypotension, 
syncope and collapse (Sisson et al., 1999; Tran-Cong 
et al., 2004; Boon, 2011; Ware, 2013; Beijerink et al., 
2017). In a case report by Kunze et al. (2002), chronic 
cyanosis due to high atrial pressure and right-to-left 
atrial shunting have been described in a dog. 
The congenital cardiac abnormality, in which the 
basal attachments of one or both tricuspid valve leaf-
lets are displaced more apically into the right ventricle 
with an ineffective closure of the TV as a conse-
quence, is called Ebstein’s anomaly (Takemura et al., 
2003). In humans, this abnormality is more commonly 
described than TVD (Malvindi and Viola, 2015). The 
etiology of Ebstein’s anomaly in dogs has not been 
investigated yet, but in humans, risk factors, such as 
previous miscarriages, maternal exposure to benzodia- 
zepine and varnish, and the intake of lithium have 
been identified (Warkany, 1988; Correa-Villasenor et 
al., 1994; Takemura et al., 2003).
Both in humans and dogs, TVD may occur as a 
single disease or in combination with other congeni-
tal cardiac malformations like mitral valve dysplasia, 
pulmonic stenosis and atrial and ventricular septal de-
fects (Kittleson, 1998; Sisson et al., 1999; Hoffmann 
et al., 2000; Famula et al., 2002). 
PREVALENCE
Tricuspid valve dysplasia represents approximately 
two to seven percent of all congenital cardiac mal-
formations in dogs (Tidholm, 1997; Baumgartner and 
Glaus, 2003; Schrope, 2015). Important is that a high 
percentage of neonate and foetuses with severe TVD 
are likely to die during gestation or shortly after, so 
the true prevalence is assumed to be higher than re-
ported (Tran-Cong, 2004; Piantedosi, 2011). 
BREED AND SEX PREDISPOSITION FOR TRI-
CUSPID VALVE DYSPLASIA AND HEREDI-
TARY ASPECTS
The most affected breed with TVD and Ebstein’s 
anomaly is the Labrador retriever (Kittleson, 1998; 
Chetboul et al., 2004; Sousa et al., 2006; Tilly and 
Smith, 2011; Paslawska et al., 2013), followed by the 
boxer, German shepherd dog, old English sheepdog, 
Great Dane, Weimaraner, golden retriever, English 
bulldog, Dogue de Bordeaux and Irish setter (Liu and 
Tilley, 1976; Konreich and Moise, 1997; Chetboul 
et al., 2004; Ohad et al., 2013). Potentially affected 
small breed dogs include the Yorkshire terrier, beagle, 
English cocker spaniel, French bulldog and poodle 
(Paslawska et al., 2013). The majority of the dogs are 
pure bred dogs (Chetboul et al., 2004). 
No clear sex predisposition has been found. In two 
studies, males seemed to be more affected than fe-
males (Tilly and Smith, 2011; Paslawska et al., 2013), 
whereas in another study (Oliveira et al., 2011) more 
females were diagnosed with TVD. In a recent preva-
lence study concerning congenital heart diseases in 
dogs, one male and one female with TVD were de-
scribed (Schrope, 2015).
The increased prevalence of TVD in some dog 
breeds suggests a genetic predisposition (Beijerink 
et al., 2017). Tricuspid valve dysplasia has been de-
scribed in Labrador retrievers as a monogenic auto-
somal dominant trait with reduced penetrance and 
with a potential susceptibility locus on chromosome 
9 (Andelfinger et al., 2003; Andelfinger et al., 2004). 
This finding was the first worldwide successful ge-
nome mapping of a locus linked to a congenital heart 
malformation in the dog. In another report, the herita-
bility for TVD in the Labrador retriever has been es-
timated to be 0.71 but, contrary to the previous study, 
a recessive inheritance has been suggested (Famula et 
al., 2002).
In the Dogue de Bordeaux, the mode of inheritance 
for TVD appears to be autosomal recessive (Ohad et 
al., 2013). The heritability and mode of inheritance 
has not yet been established in other dog breeds (Tilly 
and Smith, 2011).
CLINICAL  FEATURES
The severity and the onset of clinical signs depend 
on the severity of the valve malformation. Many dogs 
are asymptomatic for several years; fifty percent of 
dogs diagnosed with TVD in the study of Paslawska 
et al. (2013) were free of clinical symptoms at the 
time of diagnosis. In the symptomatic phase, exercise 
intolerance in combination with a heart murmur on 
physical examination is the most common symptom 
(Chetboul et al., 2004). Anorexia and cardiac cachex-
ia are also frequently observed. Additionally, jugular 
vein distension and pulsation are common findings. 
Hepatomegaly and ascites may occur in case of right-
sided congestive heart failure (Beijerink et al., 2017).
DIAGNOSIS OF TRICUSPID VALVE DYSPLASIA
The tentative diagnosis of TVD can be made based 
on physical examination, radiography and electrocar-
diography, but echocardiography is necessary to con-
firm the diagnosis. 
Vlaams Diergeneeskundig Tijdschrift, 2018, 87 17
On physical examination, a right-sided holosystolic 
heart murmur may be heard but it is not necessarily 
present (Ware, 2013). The intensity of the murmur 
does not correlate with the severity of the disease; 
dogs with a relatively soft systolic murmur may have 
severe malformations. Rarely, a soft diastolic rumble 
can be auscultated that is suggestive for a concurring 
tricuspid stenosis. In case of congestive heart failure, 
a murmur may no longer be present because of the 
loss of resistance of the valve leaflets against the re-
gurgitation. In this stage of the disease, an increased 
jugular venous pressure, ascites and pleural effusion 
may also be present (Kittleson, 1998; Sisson et al., 
1999; Chetboul et al., 2004; Beijerink et al., 2017).
Thoracic radiographs of dogs with severe TVD may 
reveal an impressive right atrial enlargement (Figure 
1). Because of the large appearance of the right atrium, 
the complete right heart may seem enlarged and the 
apex is often pushed towards the left side of the tho-
rax. The large right atrium can be seen as a well-delin-
eated structure in the thorax. When this abnormality 
is seen in a young dog with a severe heart murmur 
located at the level of the TV, this finding is pathogno-
monic for severe tricuspid regurgitation. In that case, 
the dog should be referred for echocardiography since 
TVD is the most likely primary problem (Kittleson, 
1998). Tricuspid valve stenosis can be suspected when 
the right atrium is severely enlarged without clear ra-
diographic signs of ipsilateral ventricular enlargement 
(Beijerink et al., 2017).
Additionally, the heart shadow may have a globoid 
appearance similar to that seen in case of pericardial 
effusion and dilated cardiomyopathy. Caudal vena 
cava distension, pleural and peritoneal effusion and 
hepatomegaly may be appreciated on thoracic radio-
graphs in severe cases of TVD (Kittleson, 1998; Tran-
Cong, 2004; Ware, 2013; Beijerink et al., 2017).
On electrocardiogram (ECG), right axis deviation 
and splintered QRS complexes are the most com-
mon findings in dogs with severe TVD (Beijerink et 
al., 2017) (Figure 3). Other signs of right atrial and 
right ventricular enlargement may also be present, 
such as tall P-waves and deep Q- and/or S-waves, 
respectively. Massive right atrial enlargement may 
lead to supraventricular tachyarrhythmia’s including 
atrial fibrillation. In dogs with Ebstein’s anomaly, a 
tall P-wave in combination with hypervoltage of the 
T-wave may be noticed (Kittleson and Kienle, 1998; 
Chetboul et al., 2004; Sousa et al., 2006; Ware, 2013). 
However, these findings are not specific for right 
atrial enlargement and an absence of these findings 
does not exclude right atrial enlargement (Kittleson, 
1998). In two case reports described by Sousa et al. 
(2006), echocardiography revealed severe right atrial 
Figure 1. A. Lateral thorax radiographs of 
a healthy eight-year-old Labrador retriever 
(left) and a five-year-old Labrador retriever 
presented with exercise intolerance and sus-
pected of TVD (right). In the right radio-
graph, the cardiac silhouette is moderately 
widened, measuring four intercostal spaces 
in width. The white arrows indicate the en-
larged right atrium. There is an increased 
sternal contact and the apex of the heart is 
retracted dorsally (black arrow); the right 
side of the cardiac silhouette has a rounded 
appearance. B. Dorsoventral thorax radio-
graphs of the same dogs. In the right image, 
the cardiac silhouette has a reverse D-shape 
(indicated on the radiography) and the white 
arrows indicate the enlarged right atrium. 
The pulmonary parenchyma shows a mod-
erate diffuse broncho-interstitial pattern. 
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and ventricular enlargement, although ECG showed 
only a right axis deviation in both dogs and deep S-
waves in one dog.
On echocardiography, the most common findings 
are the enlarged right atrium and eccentric hypertro-
phy of the right ventricle (Kittleson, 1998). The right 
atrial volume overload should be obvious and more 
severe than the right ventricular volume overload. 
The left atrium and ventricle are frequently reduced in 
size. The malformed TV can be visualized on multiple 
views, but the left parasternal or apical four-chamber 
view appears to be the view of choice (Boon, 2011). 
When the septal leaflet is tethered to the interventricu-
lar septum, the middle part of the leaflet often moves 
away from the septum while the ends of the leaflet 
remain closely opposed to the septum (Figure 2). In 
these cases, the mural leaflet is typically elongated 
and closure of the TV is almost effective during sys-
tole (Boon, 2011; Beijerink et al., 2017).
Color Doppler imaging is used to identify turbulent 
regurgitant jets streaming from the ventricle through 
the incompetent valve into the right atrium during 
systole. In healthy dogs, trivial tricuspid regurgitation 
may occur and this finding should not be mistaken for 
a tricuspid valve disease (Boon, 2011). In dogs with 
uncomplicated TVD, the velocity of the regurgitant 
jet is in the range of 1.5 to 3 m/sec, measured with the 
continuous wave Doppler. A diastolic pressure gradi-
ent can be recorded by Doppler ultrasound across the 
TV when the TVD results in tricuspid stenosis and is 
thus complicated (Yuill, 1991; Kittleson and Kienle, 
1998; Sisson et al., 1999; Tilly and Smith, 2011; Bei-
jerink et al., 2017). In that case, color flow Doppler 
studies show increased diastolic flow velocities as 
high as 2.6 m/s entering the right ventricle while the 
normal maximal diastolic tricuspid flow velocity is 
usually less than 1.0 m/s (Brown and Thomas, 1995; 
Kunze et al., 2002). 
In case of Ebstein’s anomaly, the right atrium is of-
ten severely enlarged and the right ventricle is usually 
atrialized because of the apical displacement of the 
tricuspid leaflets (Boon, 2011) (Figure 3). In the nor-
mal canine heart, the annulus of the tricuspid and mi-
tral valve are nearly aligned, although the physiologic 
insertion point of the tricuspid annulus lies slightly 
more apical than the mitral annulus with a maximum 
difference of 2 mm. The annulus can be identified on 
the right parasternal long-axis-four-chamber views of 
the heart (Boon, 2011). 
Figure 2 A. Right parasternal four-chamber view of a five-year-old Labrador retriever without echocardiographic 
abnormalities (left) and a one-year-old Labrador retriever with TVD (right). Note the severe dilation of the right heart 
and the abnormal morphology of the TV with the septal leaflet tethered to the interventricular septum (arrow). B. Left 
apical four-chamber view in systole of the same dogs. Note the severe right atrial enlargement and the elongated and 
thickened anterior leaflet tethered to the interventricular septum. 
RA: right atrium; LA: left atrium; RV: right ventricle; LV: left ventricle; TV: tricuspid valve.
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TREATMENT OF TRICUSPID VALVE DYS-
PLASIA
Pharmaceutics provide conservative support and 
are the most frequently used treatment in dogs (Arai 
et al., 2011). This treatment is necessary once the dogs 
show signs of decompensation. The effect of preven-
tive treatment before the onset of clinical signs is 
unknown (Beijerink et al., 2017). Angiotensin-con-
verting enzyme (ACE) inhibitors are advised in an 
attempt to prevent the progression of the congestive 
heart failure by reducing the abnormal cardiovascular 
remodelling. These inhibitors also reduce sodium and 
water retention. Positive inotropic products are given 
to improve right ventricular systolic function and are 
needed in cases of right-sided cardiac failure. Diure- 
tics such as furosemide are essential to control signs 
of congestion. As a loop diuretic, furosemide causes 
excretion of sodium, potassium, chloride, calcium, 
magnesium and water. A well-balanced diet with low 
sodium and sufficient energy and protein is also in-
dicated. In case of acute presentation of dyspnea and 
ascites, oxygen therapy, thoracocenthesis and/or ab-
dominocenthesis will be necessary (Paslawska et al., 
2013; Beijerink et al., 2017). In case of the presence 
of atrial fibrillation or supraventricular tachycardia, 
digoxin, calcium channel blockers and beta-blockers 
can be administered for rate control (Ware, 2013; Bei-
jerink et al., 2017).
The treatment of significant tricuspid regurgitation 
due to TVD in human medicine exists of surgical val-
vuloplasty or valve replacement. Both bioprostheses 
and mechanical prostheses are used for artificial valve 
replacement. The principal advantage of mechanical 
prostheses compared to bioprostheses is the durability 
(Arai et al., 2011; Bristow et al., 2017). 
Arai et al. (2011) performed TV replacement in 
dogs with clinical signs of TV regurgitation due to 
TVD with bovine pericardial (n=5) or porcine aortic 
bioprostheses (n=7). Anticoagulation therapy was ad-
ministered to all dogs to prevent potential thrombosis. 
In this study, execution and post-operative hospital-
ization were successful in ten out of twelve dogs. One 
dog died at home ten days after the surgical inter-
vention due to atrial flutter and cyanosis associated 
with an uncorrected foramen ovale. Two dogs were 
euthanized ten and thirteen months after surgery due 
to implant failure of the bioprosthesis because of in-
flammatory pannus (Arai et al., 2011). The remaining 
seven dogs showed complete resolution of TV regur-
gitation with good quality of life for a median period 
of 48 months. Other non-fatal complications reported 
after surgery included thrombosis, atrial flutter or fi-
brillation and endocarditis. 
Bristow et al. (2017) also recently reported the 
outcome after bioprosthetic valve replacement in nine 
dogs with clinical signs of congestive heart failure 
due to TVD. Again, bovine pericardial valves (n=8) 
as well as porcine aortic valves (n=1) were implanted. 
All dogs received anticoagulation therapy to prevent 
thrombosis. Five dogs had fatal complications in the 
postoperative period (problems regarding coagula-
tion and septicemia). The median survival time of the 
four remaining dogs was approximately one year. Of 
these four dogs, two dogs ultimately died as a result 
of valve stenosis due to inflammatory pannus or orga-
nized thrombus. Thus, outcomes after surgical valve 
replacement were in this study associated with a high 
incidence of complications. An explanation for the 
higher mortality rate in this study than in the study of 
Arai et al. is difficult as the executed technique was 
similar in both studies. The only difference was the 
protocol for the anticoagulation therapy; warfarin 
therapy was initiated the day after heparin administra-
tion, whereas in the study of Arai et al., an interval of 
two days was respected.
Figure 3. Right parasternal four-chamber views of a 
dog with Ebstein’s anomaly. The tricuspid annulus is 
displaced apically into the right ventricle. A. The small 
arrow indicates the displaced TV; the normal point 
of attachment of the tricuspid valve is shown with the 
large arrow. B. The long arrow indicates the tricuspid 
annulus, clearly apically located. The orange circle 
indicates a concomitant patent foramen ovale. 
RA: right atrium; LA: left atrium; RV: right ventricle; 
LV: left ventricle; VS: ventricular septum (Adapted 
from Boon, 2011). 
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Aside from the complication risks, the specialized 
technical approach, the necessity of an extra-corporal 
fluid circulation and the high costs limit the applica-
tion in veterinary medicine (Sisson et al., 1999; Arai 
et al., 2011; Paslawska et al., 2013). 
The main limitation for the use of bioprosthesis in 
human medicine is the shorter durability compared to 
mechanical prosthesis. The degradation of a biopros-
thesis begins already after ten to fifteen years, but tak-
ing the shorter life expectancy of dogs into account, 
this might be less important or less of an issue in dogs 
(Rizzoli et al., 2003; David et al., 2010). 
In human medicine, tricuspid stenosis can be 
surgically corrected by performing balloon valvulo- 
plasty. In three case-reports, transcatheter balloon 
valvuloplasty in dogs with tricuspid stenosis has been 
described (Brown and Thomas, 1995; Kunze et al., 
2002; Lake-Bakaar et al., 2017) with markedly lower 
and clinically acceptable diastolic peak velocities at 
the level of TV several months after surgery. How-
ever, recurrence of heart failure may occur.
PROGNOSIS OF TRICUSPID VALVE DYSPLA-
SIA
The prognosis of TVD depends on several factors 
including the degree of valvular malformation, the 
presence of other congenital cardiac malformations 
and the severity of the cardiomegaly. Dogs with small 
insufficiencies usually have a normal life span (Bei-
jerink et al., 2017). Negative prognostic factors are 
a high-velocity regurgitant flow through the dysplas-
tic TV during systole, right sided cardiac failure and 
atrial fibrillation. Some dogs may have a good quality 
of life for several years under medication while others 
have a rapid progression of the disease (Beijerink et 
al., 2017). 
The prognosis for Ebstein’s anomaly is worse as 
congestive cardiac failure develops frequently before 
the age of one year and cardiac arrhythmias are com-
mon (Chetboul et al., 2004).
CONCLUSION
Tricuspid valve dysplasia is generally considered 
to be a relatively rare congenital heart malformation 
in the dog. The disease can remain asymptomatic for 
several years. Based on physical examination, radio- 
graphy and/or electrocardiography, TVD can be pre-
sumed, but formal diagnosis is based on echocardio- 
graphy. Surgical intervention as a curative treatment 
is still in its experimental phase. The current thera-
py exists of the administration of positive inotropic 
drugs, diuretics and ACE inhibitors once the patient 
shows clinical symptoms. 
This condition probably has a genetic base, es-
pecially in the Labrador retriever, but also in other 
breeds. Further genetic research is necessary to iden-
tify the disease-causing mutations for TVD. Because 
the mutation has not been identified yet, dogs that are 
related to an affected animal should be screened using 
echocardiography before breeding. 
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